FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to derivatives of pyridazine of the general formula (I) where R1 means phenyl or pyridyl group that can be substituted by 1-3 substituents taken among halogen atom and lower alkoxy-groups; R2 means phenyl group that can be substituted at position 4 by lower alkoxy-group, lower alkylthio-group, lower alkylsulfinyl or lower alkylsulfonyl group and by 1 or 2 substituents at other positions taken among halogen atom, lower alkoxyl groups, lower alkylthio groups, lower alkylsulfinyl groups and lower alkylsulfonyl groups; R3 means hydrogen atom, lower alkoxyl- group, halogenated lower alkyl group, lower cycloalkyl group, phenyl, pyridyl or phenyloxy-group that can be substituted by 1-3 substituents taken among halogen atoms, lower alkyl groups, lower alkoxyl groups, carboxyl group, lower alkoxycarbonyl groups, nitro-group, amino-group, lower alkylamino groups and lower alkylthio groups; piperidino-group, piperidinyl group, piperazino-group or morpholino-group that can be unsubstituted or substituted by lower alkyl group; aminocarbonyl group that can be unsubstituted or substituted by benzyl group; lower alkylcarbonyl group; or piperazinocarbonyl group that can be unsubstituted or substituted by lower alkylyl group; A means linear or branched lower alkylene or lower alkenylene group comprising 1-6 carbon atoms; or A can mean a direct linkage when R3 means lower cycloalkyl or halogenated lower alkyl group; X means oxygen or sulfur atom under condition that the following combinations are excluded: R1 and R2 mean 4-methoxyphenyl group; X means oxygen atom; A means a direct linkage and R3 means hydrogen atom or 2-chloroethyl group; or their salts. Indicated compounds are inhibitors of interleukin-1 β producing. Except for, invention relates also to medicinal agent that is inhibitor of production of interleukin-1 β, medicinal agent used for prophylaxis and treatment of patients with arthritis and method for treatment of patient with arthritis. EFFECT: valuable medicinal properties of compounds. 8 cl, 4 tbl, 172 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF PYRIDAZINE-3-ONE AND MEDICINAL AGENTS COMPRISING THEREOF | 2000 |
|
RU2232755C2 |
NEW DERIVATIVES OF PYRIDAZINE AND MEDICINAL AGENT COMPRISING THEREOF AS EFFECTIVE COMPONENTS | 1999 |
|
RU2221790C2 |
PHENYLPYRIDAZINE COMPOUNDS AND MEDICINAL AGENTS COMPRISING THEREOF | 2001 |
|
RU2269519C2 |
APPLICATION OF BENZOPHENOL DERIVATIVE OR ITS SALT AND TNF-α INHIBITOR IN COMBINATION, AND PHARMACEUTICAL COMPOSITION, CONTAINING THEREOF OR ITS SALT AND INHIBITOR | 2009 |
|
RU2522272C2 |
NOVEL DIAMINE CYCLIC COMPOUNDS MEDICINAL AGENTS COMPRISING THEREOF AND METHODS OF TREATMENT | 1998 |
|
RU2207341C2 |
PYRIDAZINONE DERIVATIVES AND METHODS OR PREPARING THEREOF | 1996 |
|
RU2131419C1 |
COMPOSITION FOR CONTROLLING AGRICULTURAL CROPS AND METHOD OF CONTROLLING DISEASES THEREOF | 1996 |
|
RU2147180C1 |
DERIVATIVES OF CARBAMATE AND AGRICULTURE FUNGICIDE | 2000 |
|
RU2228328C2 |
METHOD OF PRODUCING DERIVATIVE OF ENDO-9-AZABICYCLO[3,3,1]NONAN-3-OLA | 2014 |
|
RU2639150C2 |
ISOXALINE DERIVATIVES AND HERBICIDES COMPRISING THEIR AS ACTIVE COMPONENTS | 2000 |
|
RU2237664C2 |
Authors
Dates
2003-08-10—Published
1998-11-09—Filed